World's Best Scientists 2026 revealed!

D-Index & Metrics

Discipline name D-Index World Ranking Current World Ranking National Ranking Current National Ranking Publications Citations
Medicine 106 6431 6050 620 592 865 50611

Peter Hoskin publications per year

The chart shows the history of publications by Peter Hoskin between 1985 and 2026, highlighting the no. of papers published in each year and offering an overview of the publication velocity of this scholar. Peter Hoskin published across 42 years, from 1985 to 2026, averaging 25.1 papers a year. Output peaked at 87 publications in 2023. 48 of the 1,053 publications appeared in the last two years.

No. of publications
20 40 60 80
Bar chart. Horizontal axis: year, 1985 to 2026. Vertical axis: number of publications, 0 to 87. Peak 87 publications in 2023. 1985: 2 publications 1986: 6 publications 1987: 5 publications 1988: 4 publications 1989: 4 publications 1990: 4 publications 1991: 6 publications 1992: 3 publications 1993: 6 publications 1994: 7 publications 1995: 3 publications 1996: 10 publications 1997: 9 publications 1998: 7 publications 1999: 9 publications 2000: 20 publications 2001: 14 publications 2002: 13 publications 2003: 36 publications 2004: 14 publications 2005: 19 publications 2006: 27 publications 2007: 34 publications 2008: 21 publications 2009: 32 publications 2010: 20 publications 2011: 30 publications 2012: 51 publications 2013: 46 publications 2014: 42 publications 2015: 21 publications 2016: 37 publications 2017: 48 publications 2018: 32 publications 2019: 40 publications 2020: 71 publications 2021: 69 publications 2022: 39 publications 2023: 87 publications 2024: 57 publications 2025: 44 publications 2026: 4 publications
1985 2026

1,053 publications in total across all disciplines

View publications per year as a table
Peter Hoskin: publications per year, 1985 to 2026
Year Publications
1985 2
1986 6
1987 5
1988 4
1989 4
1990 4
1991 6
1992 3
1993 6
1994 7
1995 3
1996 10
1997 9
1998 7
1999 9
2000 20
2001 14
2002 13
2003 36
2004 14
2005 19
2006 27
2007 34
2008 21
2009 32
2010 20
2011 30
2012 51
2013 46
2014 42
2015 21
2016 37
2017 48
2018 32
2019 40
2020 71
2021 69
2022 39
2023 87
2024 57
2025 44
2026 4
Total 1,053
Download as CSV

Peter Hoskin publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Peter Hoskin sits on this spectrum.

No. of scientists
200 400 600 800
Bar chart with 86 bars. Horizontal axis: publications, 101–120 to 1,796+. Vertical axis: number of scientists, 0 to 922. Most scientists, 922, have 341–360 publications. The last bar groups every scientist with 1,796 publications or more. The highlighted bar, 861–880 publications, is where this scientist sits. 101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101–120 publications 1,796+

This scientist: 865 publications — 90th percentile

90% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

View publications distribution as a table
Number of Medicine scientists by publication count, Research.com 2026 ranking edition. Based on 20,134 ranked scientists.
Publications Scientists This scientist
101–120 5
121–140 26
141–160 73
161–180 155
181–200 230
201–220 363
221–240 487
241–260 545
261–280 722
281–300 768
301–320 834
321–340 895
341–360 922
361–380 838
381–400 861
401–420 918
421–440 806
441–460 771
461–480 751
481–500 713
501–520 617
521–540 610
541–560 537
561–580 504
581–600 509
601–620 396
621–640 386
641–660 371
661–680 340
681–700 336
701–720 307
721–740 259
741–760 230
761–780 228
781–800 217
801–820 204
821–840 186
841–860 177
861–880 155 865
881–900 139
901–920 145
921–940 116
941–960 133
961–980 91
981–1,000 96
1,001–1,020 77
1,021–1,040 70
1,041–1,060 63
1,061–1,080 77
1,081–1,100 49
1,101–1,120 54
1,121–1,140 49
1,141–1,160 51
1,161–1,180 35
1,181–1,200 39
1,201–1,220 26
1,221–1,240 37
1,241–1,260 36
1,261–1,280 27
1,281–1,300 32
1,301–1,320 28
1,321–1,340 17
1,341–1,360 30
1,361–1,380 28
1,381–1,400 17
1,401–1,420 21
1,421–1,440 15
1,441–1,460 12
1,461–1,480 12
1,481–1,500 18
1,501–1,520 14
1,521–1,540 17
1,541–1,560 15
1,561–1,580 6
1,581–1,600 2
1,601–1,620 12
1,621–1,640 11
1,641–1,660 8
1,661–1,680 5
1,681–1,700 5
1,701–1,720 10
1,721–1,740 12
1,741–1,760 14
1,761–1,780 6
1,781–1,795 5
1,796+ 100
Download as CSV

Peter Hoskin D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Peter Hoskin sits on this spectrum.

No. of scientists
250 500 750 1,000
Bar chart with 75 bars. Horizontal axis: D-Index, 70–71 to 217+. Vertical axis: number of scientists, 0 to 1,027. Most scientists, 1,027, have 82–83 D-Index. The last bar groups every scientist with 217 D-Index or more. The highlighted bar, 106–107 D-Index, is where this scientist sits. 70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70–71 D-Index 217+

This scientist: 106 D-Index — 69th percentile

69% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

View D-Index distribution as a table
Number of Medicine scientists by D-index, Research.com 2026 ranking edition. Based on 20,134 ranked scientists.
D-Index Scientists This scientist
70–71 226
72–73 391
74–75 574
76–77 730
78–79 891
80–81 972
82–83 1,027
84–85 1,003
86–87 960
88–89 970
90–91 922
92–93 839
94–95 808
96–97 779
98–99 668
100–101 611
102–103 630
104–105 513
106–107 541 106
108–109 445
110–111 429
112–113 399
114–115 393
116–117 318
118–119 302
120–121 287
122–123 255
124–125 256
126–127 252
128–129 230
130–131 179
132–133 168
134–135 163
136–137 159
138–139 134
140–141 134
142–143 118
144–145 109
146–147 106
148–149 74
150–151 79
152–153 80
154–155 87
156–157 57
158–159 74
160–161 69
162–163 60
164–165 53
166–167 39
168–169 42
170–171 32
172–173 39
174–175 40
176–177 28
178–179 19
180–181 23
182–183 31
184–185 18
186–187 20
188–189 22
190–191 13
192–193 21
194–195 12
196–197 12
198–199 14
200–201 15
202–203 13
204–205 10
206–207 8
208–209 4
210–211 12
212–213 11
214–215 10
216 4
217+ 98
Download as CSV

Overview

Peter Hoskin is affiliated with the University of Manchester in the United Kingdom. Their research primarily falls within the broad field of Medicine, with focused contributions to Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging, Surgery, Radiation, and Obstetrics and Gynecology.

Their work covers several major topics related to cancer treatment and radiotherapy. These include Advanced Radiotherapy Techniques, Prostate Cancer Diagnosis and Treatment, Endometrial and Cervical Cancer Treatments, Management of metastatic bone disease, Prostate Cancer Treatment and Research, Bladder and Urothelial Cancer Treatments, and Radiomics and Machine Learning in Medical Imaging.

Peter Hoskin has co-authored frequently with several researchers in their field. Notable frequent collaborators include Ananya Choudhury, Catharine West, Kari Tanderup, Bradley R. Pieters, and Richard Pötter.

Publications by Peter Hoskin have appeared most frequently in the following journals and venues:

  • Radiotherapy and Oncology
  • International Journal of Radiation Oncology*Biology*Physics
  • Clinical Oncology
  • Annals of Palliative Medicine
  • Brachytherapy

Recent papers authored or co-authored by Peter Hoskin include:

  • "MRI-guided adaptive brachytherapy in locally advanced cervical cancer (EMBRACE-I): a multicentre prospective cohort study" (2021) published in The Lancet Oncology
  • "Sarcopenia in cancer: Risking more than muscle loss" (2020) published in Technical Innovations & Patient Support in Radiation Oncology
  • "European Society for Radiotherapy and Oncology and European Organisation for Research and Treatment of Cancer consensus on re-irradiation: definition, reporting, and clinical decision making" (2022) published in The Lancet Oncology
  • "Hypofractionated radiotherapy in locally advanced bladder cancer: an individual patient data meta-analysis of the BC2001 and BCON trials" (2021) published in The Lancet Oncology
  • "Radiotherapy to the prostate for men with metastatic prostate cancer in the UK and Switzerland: Long-term results from the STAMPEDE randomised controlled trial" (2022) published in PLoS Medicine

Best Publications

  • Alpha Emitter Radium-223 and Survival in Metastatic Prostate Cancer

    C. Parker;S. Nilsson;S. Nilsson;D. Heinrich;S. I. Helle

  • Abiraterone for Prostate Cancer Not Previously Treated with Hormone Therapy

    Nicholas D. James;Johann S. de Bono;Melissa R. Spears;Noel W. Clarke

  • The UK Standardisation of Breast Radiotherapy (START) Trial B of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial.

    Bentzen Sm;Agrawal Rk;Aird Eg

  • Palliative radiotherapy for bone metastases: an ASTRO evidence-based guideline.

    Stephen Lutz;Lawrence Berk;Eric Chang;Edward Chow

  • The UK Standardisation of Breast Radiotherapy (START) Trial A of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial.

    Bentzen Sm;Agrawal Rk;Aird Eg

  • Management of cancer pain in adult patients: ESMO Clinical Practice Guidelines.

    M Fallon;R Giusti;F Aielli;P Hoskin

  • Magnetic Resonance Imaging for the Detection, Localisation, and Characterisation of Prostate Cancer: Recommendations from a European Consensus Meeting

    Louise Dickinson;Louise Dickinson;Louise Dickinson;Hashim U. Ahmed;Hashim U. Ahmed;Clare Allen;Jelle O. Barentsz

  • The EMBRACE II study: The outcome and prospect of two decades of evolution within the GEC-ESTRO GYN working group and the EMBRACE studies

    Richard Pötter;Kari Tanderup;Christian Kirisits;Astrid de Leeuw

  • Results of a trial of PET-directed therapy for early-stage Hodgkin's lymphoma.

    John Radford;Tim Illidge;Nicholas Counsell;Barry Hancock

  • Image guided brachytherapy in locally advanced cervical cancer: Improved pelvic control and survival in RetroEMBRACE, a multicenter cohort study.

    Alina Sturdza;Richard Pötter;Lars Ulrik Fokdal;Christine Haie-Meder

  • Long-term effect of a watch and wait policy versus immediate systemic treatment for asymptomatic advanced-stage non-Hodgkin lymphoma: a randomised controlled trial.

    KM Ardeshna;P Smith;A Norton;BW Hancock

  • Effect of radium-223 dichloride on symptomatic skeletal events in patients with castration-resistant prostate cancer and bone metastases: results from a phase 3, double-blind, randomised trial

    Oliver Sartor;Robert E Coleman;Sten Nilsson;Daniel Heinrich

  • Adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): final results of an international, open-label, multicentre, randomised, phase 3 trial

    Stephanie M. de Boer;Melanie E. Powell;Linda Mileshkin;Dionyssios Katsaros

  • Prospective randomised trial of single and multifraction radiotherapy schedules in the treatment of painful bony metastases.

    P. Price;P.J. Hoskin;D. Easton;D. Austin

  • Randomised trial of external beam radiotherapy alone or combined with high-dose-rate brachytherapy boost for localised prostate cancer

    Peter J. Hoskin;Ana M. Rojas;Peter J. Bownes;Gerry J. Lowe

  • Myocardial Infarction Mortality Risk After Treatment for Hodgkin Disease: A Collaborative British Cohort Study

    Anthony J. Swerdlow;Craig D. Higgins;Paul Smith;David Cunningham

  • Survival with Newly Diagnosed Metastatic Prostate Cancer in the "Docetaxel Era": Data from 917 Patients in the Control Arm of the STAMPEDE Trial (MRC PR08, CRUK/06/019)

    Nicholas David James;Melissa R. Spears;Noel W. Clarke;David P. Dearnaley

  • Non-Small Cell Lung Cancer: Histopathologic Correlates for Texture Parameters at CT

    Balaji Ganeshan;Vicky Goh;Henry C. Mandeville;Quan Sing Ng

  • Efficacy and safety of radium-223 dichloride in patients with castration-resistant prostate cancer and symptomatic bone metastases, with or without previous docetaxel use: a prespecified subgroup analysis from the randomised, double-blind, phase 3 ALSYMPCA trial

    Peter Hoskin;Oliver Sartor;Joe M O'Sullivan;Dag Clement Johannessen

  • Adjuvant chemoradiotherapy versus radiotherapy alone in women with high-risk endometrial cancer (PORTEC-3): patterns of recurrence and post-hoc survival analysis of a randomised phase 3 trial

    Stephanie M de Boer;Melanie E Powell;Linda Mileshkin;Dionyssios Katsaros

Frequent Co-Authors

Richard Pötter
Richard Pötter Medical University of Vienna
Edward Chow
Edward Chow Sunnybrook Health Science Centre
Christine Haie-Meder
Christine Haie-Meder Institut Gustave Roussy
Catharine M L West
Catharine M L West University of Manchester
Anwar R. Padhani
Anwar R. Padhani Northwood University
Chris Parker
Chris Parker Institute of Cancer Research
David C. Linch
David C. Linch University College London
Steven E. Schild
Steven E. Schild Mayo Clinic
John Yarnold
John Yarnold Institute of Cancer Research
Søren M. Bentzen
Søren M. Bentzen University of Maryland, Baltimore

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re interested in studying Medicine in the USA, there are several related online degrees and career pathways to consider. These programs can help you gain vital skills in the healthcare field, often with flexible study options that fit your schedule.

For those aiming to start or advance a nursing career, absn programs that don't require teas offer a streamlined path to becoming a nurse without the added requirement of standardized entrance exams. Nurses looking to take the next step may benefit from rn to np bridge programs, which allow registered nurses to efficiently progress towards advanced practice roles.

If your interests lie in the business side of healthcare, consider earning an accelerated healthcare administration degree. These programs prepare you for leadership positions in hospitals and medical organizations. Additionally, a passion for wellness and patient nutrition can be pursued through online degrees in nutrition, opening doors to roles in clinical nutrition, public health, and more.

Best Scientists Citing Peter Hoskin

Trending Scientists

Recently Published Articles